Legal Representation
Attorney
Charles T. J. Weigell
USPTO Deadlines
Next Deadline
531 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-01-12)
Due Date
January 12, 2027
Grace Period Ends
July 12, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
37 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 4, 2021 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| May 11, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Apr 20, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Apr 20, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Apr 12, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jan 12, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 19, 2020 | LIMN | I | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
| Oct 27, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 27, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 25, 2020 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Oct 7, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 7, 2020 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Oct 7, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Sep 23, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Sep 23, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 23, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 23, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 23, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 18, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 18, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 27, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 27, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 27, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 27, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Jul 27, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 27, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| May 22, 2020 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Apr 10, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 24, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 24, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 4, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 2, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 18, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 14, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 13, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010